Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

RPS conference attendees divided over remote supervision

Remote supervision divided debate among attendees at a fringe session on supervision at the RPS Conference in London this week.

Chaired by vice-chair of the English Pharmacy Board Sid Dajani, the debate centred on the eight principles for supervision released by the RPSGB last month. These include a declaration that all patients should have their medicines supply overseen by a pharmacist.

Independent pharmacist Graham Phillips responded: “I am not willing to remove the pharmacist from the scene. As a clinician I am not willing to do that.


“You can’t say you can be out of the pharmacy for two hours as you don’t know what’s going to happen in those two hours.” 

The debate comes ahead of an expected government bid to review existing supervision laws next year.

Changes could see pharmacists able to run pharmacies without being physically present.

This remote supervision concept has been heavily criticised by the industry, but attendees from Wales and Scotland argued the concept could ensure patients in remote parts of the UK had access to services.

Director of pharmacy for NHS Highland John Cromarty said: “Remote access is a problem, the area I cover has an area of 12,500 square miles. Many patients have no access to community pharmacy.”

Debate attendees also questioned how the RPS will engage members  in the supervision consultation.

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD013154

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel